CNOT7 Activators
The chemical class of CNOT7 Activators includes compounds that can indirectly influence CNOT7 function through their roles in modulating mRNA stability, degradation pathways, and gene expression. CNOT7, being involved in mRNA deadenylation and degradation, is influenced by changes in transcriptional dynamics, mRNA processing, and overall gene expression patterns.
Proteasome inhibitors like MG132 and Bortezomib can affect mRNA stability and degradation, potentially impacting the function of CNOT7 in these processes. Similarly, compounds affecting transcription and RNA synthesis, such as Actinomycin D and Triptolide, could indirectly impact CNOT7's activity in mRNA processing and degradation. Additionally, HDAC inhibitors such as Trichostatin A, Sodium Butyrate, and Vorinostat, by altering chromatin structure and gene expression, can potentially modulate the activity of CNOT7. Changes in chromatin dynamics and gene expression are critical for the regulation of proteins involved in mRNA processing and degradation, including CNOT7.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can affect mRNA stability and degradation pathways, potentially influencing CNOT7 activity. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
An inhibitor of nuclear export, could affect mRNA processing and potentially influence CNOT7 activity. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Affects RNA Polymerase II activity, potentially influencing CNOT7 activity by altering transcriptional dynamics. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, potentially impacting gene expression and indirectly affecting CNOT7 function. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor, could influence mRNA degradation processes involving CNOT7. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor, affecting chromatin structure and gene expression, potentially influencing CNOT7. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Another HDAC inhibitor, can impact gene expression, potentially modulating CNOT7 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, could impact CNOT7 by affecting cell growth and protein synthesis pathways. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor, could influence CNOT7 activity through changes in gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor, might affect CNOT7 by altering chromatin structure and gene expression patterns. | ||||||